Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target

Heart failure (HF) and atrial fibrillation (AF) are two cardiovascular (CV) entities that affect millions of individuals worldwide and their prevalence is translated into a significant impact on health care systems. The common pathophysiological pathways that these two share have created an importan...

Full description

Bibliographic Details

Published in:	Cardiology Journal
Main Authors:	Ioanna Koniari, Eleni Artopoulou, Virginia Mplani, Francesk Mulita, Evangelia Alexopoulou, Emmanouil Chourdakis, Mohammed Abo-Elseoud, Grigorios Tsigkas, Ioannis Panagiotopoulos, Nicholas Kounis, Dimitrios Velissaris
Format:	Article
Language:	English
Published:	Via Medica 2023-04-01
Subjects:	renin–angiotensin–aldosterone system (RAAS) blockers atrial fibrillation heart failure angiotensin receptor blockers (ARBs) angiotensin converting enzyme inhibitors (ACEIs) aldosterone antagonists (AAs)
Online Access:	https://journals.viamedica.pl/cardiology_journal/article/view/86534